The purpose of this study is determine the safety, tolerability, and efficacy of 3 doses of lecozotan SR in patients with mild to moderate Alzheimer's Disease over 12 weeks.
evaluation of long term therapy with 3 doses of lecozotan sr ( 2, 5, and 10 mg)administered to patients with AD who have completed week 12 evaluations in the short-term study. Patient duration is 42 weeks. Arms include lecozotan sr 2 mg, 5mg, and 10 mg as well as donepezil.
10 mg donepezil QD dosed up to 40 weeks
Av. Belgrano, Argentina
Calle Adolfo Alsina, Argentina
Cervino, Argentina
Gascon, Argentina
Larrea, Argentina
Nueva York, Argentina
Pilar, Argentina
Puerto Galván, Argentina